11/14/2024 3:52 PM | ARMISTICE CAPITAL, LLC (Filed by) FibroGen (Subject)
| Form SC 13G/A | |
11/12/2024 1:33 PM | FibroGen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 11:11 AM | FibroGen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/03/2024 3:05 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2024 7:00 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 7:00 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 7:00 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/07/2024 4:05 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 4:10 PM | FibroGen (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/10/2024 11:15 PM | FibroGen (Filer)
| Form EFFECT | |
07/08/2024 3:32 PM | BlackRock Inc. (Filed by) FibroGen (Subject)
| Form SC 13G/A | |
06/28/2024 4:08 PM | FibroGen (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/26/2024 7:00 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:30 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:30 PM | Adib Deyaa (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:37 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:00 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:00 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:12 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 7:00 PM | Blaug Suzanne (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | EDWARDS JEFFREY L (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | Brennan Aoife (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | Cravatt Benjamin (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Ho Maykin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Lema Gerald (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 6:46 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 8:55 PM | FibroGen (Filer)
| Form ARS | |
04/24/2024 4:01 PM | FibroGen (Filer)
| Form DEF 14A | |
04/24/2024 4:08 PM | FibroGen (Filer)
| Form DEFA14A | |
04/24/2024 3:15 PM | Adib Deyaa (Reporting) FibroGen (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/25/2024 4:58 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 6:06 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:17 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:18 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:19 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 7:33 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 7:28 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 7:29 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:37 PM | ARMISTICE CAPITAL, LLC (Filed by) FibroGen (Subject)
| Form SC 13G | |
02/05/2024 7:08 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
12/26/2023 6:28 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:19 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:20 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:21 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |